<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02643394</url>
  </required_header>
  <id_info>
    <org_study_id>052015-068</org_study_id>
    <nct_id>NCT02643394</nct_id>
  </id_info>
  <brief_title>Efficacy of Oral vs. Intravenous Acetaminophen</brief_title>
  <official_title>The Comparative Efficacy of Oral vs. Intravenous Acetaminophen in Sinus Surgery Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The comparative efficacy of intravenous (IV) to oral (PO-'per os') acetaminophen in the
      management of postoperative pain is understudied and largely unknown. In this observer
      blinded randomized clinical trial, investigators aim to determine the comparative efficacy of
      PO (preoperative) vs. IV (intraoperative) acetaminophen in a sinus surgery population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The comparative efficacy of intravenous (IV) to oral (PO-'per os') acetaminophen is
      understudied and largely unknown. Intravenous acetaminophen has been available since 2010
      (http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022450lbl.pdf) and has proven
      superiority over placebo in human clinical trials. It is clearly advantageous in patients who
      cannot take oral medications. Similarly, oral acetaminophen has proven efficacy in the
      management of postoperative pain.

      However, in patients who can receive either formulation the incremental cost of the IV
      formulation, both to the Health System and patient, is substantial. This incremental cost
      would be justifiable if there were clear efficacy or safety data to support the preferential
      use of IV over PO acetaminophen.

      However, there is no evidence of superior safety and there are only two studies to our
      knowledge investigating the question of comparative efficacy. Fenlon et al. randomized 130
      patients undergoing 3rd molar (i.e., wisdom tooth) removal to IV vs. PO acetaminophen and
      found that PO acetaminophen was non-inferior to IV acetaminophen. The primary endpoint was
      postoperative pain score 1h after surgery. No safety concerns were identified in either
      group. Pettersson et al. randomized cardiac surgery patients to IV or PO acetaminophen,
      starting immediately postoperatively through the following morning, and found a significant
      opioid sparing effect of IV acetaminophen but no difference in pain scores or nausea.

      IV acetaminophen avoids first-pass hepatic metabolism and therefore generates higher serum
      and cerebrospinal fluid (CSF)/brain levels than does PO acetaminophen
      (http://ofirmev.com/Pharmacokinetics/). Based on the pharmacokinetic data, one can
      hypothesize that IV acetaminophen would be superior to PO acetaminophen at time points where
      serum and/or cerebrospinal fluid drug levels are higher.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 17, 2015</start_date>
  <completion_date type="Actual">January 15, 2018</completion_date>
  <primary_completion_date type="Actual">September 2, 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Pain Score on the Scale of 10 (0=No Pain and 10=Worst Pain)</measure>
    <time_frame>1-h postoperatively</time_frame>
    <description>Pain score on the scale of 10 at 1-h postoperatively in the Post-Anesthesia Care Unit (PACU)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morphine Equivalents of Postoperative Opioid Usage</measure>
    <time_frame>an expected average of 6 hours</time_frame>
    <description>Total amount of postoperative opioid usage at Postoperative Anesthesia Care Unit (PACU), an expected average of 6 hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Oral Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral Acetaminophen 1-hour before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous Acetaminophen within 1-hour prior to anesthetic emergence</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral Acetaminophen</intervention_name>
    <description>1000mg oral acetaminophen + 400mg oral celecoxib given within one hour of incision</description>
    <arm_group_label>Oral Acetaminophen</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous acetaminophen</intervention_name>
    <description>400mg oral celecoxib given within one hour of incision + 1000mg IV acetaminophen within one hour prior to anesthetic emergence.</description>
    <arm_group_label>Intravenous Acetaminophen</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients aged 18 years or older

          -  Undergoing elective sinus surgery at Zale Lipshy Hospital

        Exclusion Criteria:

          -  Inability of the patient to follow directions or comprehend either English or Spanish
             language.

               -  Disorders of the liver which would make acetaminophen contraindicated (such as
                  hepatitis, liver failure, prior liver transplant, etc).

               -  Patients with chronic pain manifest by a baseline pain score &gt; 4/10

               -  Chronic opioid use (&gt;2 weeks continuously), or illicit drug abuse

               -  Body weight &lt; 50 kg.

               -  Patients with contraindications to any of the study drugs (such as Malignant
                  Hyperthermia susceptible, celecoxib or sulfa allergy, etc.).

               -  Patients who have taken analgesic medications on the morning of surgery (prior to
                  arrival).

               -  Allergy to acetaminophen
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David McDonagh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zale Lipshy University Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2015</study_first_submitted>
  <study_first_submitted_qc>December 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2015</study_first_posted>
  <results_first_submitted>November 10, 2017</results_first_submitted>
  <results_first_submitted_qc>April 4, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">May 7, 2018</results_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acetaminophen</keyword>
  <keyword>Postoperative pain</keyword>
  <keyword>Sinus Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Oral Acetaminophen</title>
          <description>Oral Acetaminophen 1-hour before surgery
Oral Acetaminophen: 1000mg oral acetaminophen + 400mg oral celecoxib given within one hour of incision</description>
        </group>
        <group group_id="P2">
          <title>Intravenous Acetaminophen</title>
          <description>Intravenous Acetaminophen within 1-hour prior to anesthetic emergence
Intravenous acetaminophen: 400mg oral celecoxib given within one hour of incision + 1000mg IV acetaminophen within one hour prior to anesthetic emergence.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Adult patients undergoing sinus surgery at a single major academic medical center</population>
      <group_list>
        <group group_id="B1">
          <title>Oral Acetaminophen</title>
          <description>Oral Acetaminophen 1-hour before surgery
Oral Acetaminophen: 1000mg oral acetaminophen + 400mg oral celecoxib given within one hour of incision</description>
        </group>
        <group group_id="B2">
          <title>Intravenous Acetaminophen</title>
          <description>Intravenous Acetaminophen within 1-hour prior to anesthetic emergence
Intravenous acetaminophen: 400mg oral celecoxib given within one hour of incision + 1000mg IV acetaminophen within one hour prior to anesthetic emergence.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="55"/>
            <count group_id="B2" value="55"/>
            <count group_id="B3" value="110"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.5" spread="16.3"/>
                    <measurement group_id="B2" value="54.0" spread="15.7"/>
                    <measurement group_id="B3" value="52.7" spread="16.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Pain Score on the Scale of 10 (0=No Pain and 10=Worst Pain)</title>
        <description>Pain score on the scale of 10 at 1-h postoperatively in the Post-Anesthesia Care Unit (PACU)</description>
        <time_frame>1-h postoperatively</time_frame>
        <population>Subjects undergoing Functional Endoscopic Sinus Surgery were enrolled to the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Oral Acetaminophen</title>
            <description>Oral Acetaminophen 1-hour before surgery
Oral Acetaminophen: 1000mg oral acetaminophen + 400mg oral celecoxib given within one hour of incision</description>
          </group>
          <group group_id="O2">
            <title>Intravenous Acetaminophen</title>
            <description>Intravenous Acetaminophen within 1-hour prior to anesthetic emergence
Intravenous acetaminophen: 400mg oral celecoxib given within one hour of incision + 1000mg IV acetaminophen within one hour prior to anesthetic emergence.</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain Score on the Scale of 10 (0=No Pain and 10=Worst Pain)</title>
          <description>Pain score on the scale of 10 at 1-h postoperatively in the Post-Anesthesia Care Unit (PACU)</description>
          <population>Subjects undergoing Functional Endoscopic Sinus Surgery were enrolled to the study.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Morphine Equivalents of Postoperative Opioid Usage</title>
        <description>Total amount of postoperative opioid usage at Postoperative Anesthesia Care Unit (PACU), an expected average of 6 hours</description>
        <time_frame>an expected average of 6 hours</time_frame>
        <population>Subjects undergoing Functional Endoscopic Sinus Surgery were enrolled to the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Oral Acetaminophen</title>
            <description>Oral Acetaminophen 1-hour before surgery
Oral Acetaminophen: 1000mg oral acetaminophen + 400mg oral celecoxib given within one hour of incision</description>
          </group>
          <group group_id="O2">
            <title>Intravenous Acetaminophen</title>
            <description>Intravenous Acetaminophen within 1-hour prior to anesthetic emergence
Intravenous acetaminophen: 400mg oral celecoxib given within one hour of incision + 1000mg IV acetaminophen within one hour prior to anesthetic emergence.</description>
          </group>
        </group_list>
        <measure>
          <title>Morphine Equivalents of Postoperative Opioid Usage</title>
          <description>Total amount of postoperative opioid usage at Postoperative Anesthesia Care Unit (PACU), an expected average of 6 hours</description>
          <population>Subjects undergoing Functional Endoscopic Sinus Surgery were enrolled to the study.</population>
          <units>Morphine equivalent (mg)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="5" lower_limit="0" upper_limit="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Through 24h post-operatively</time_frame>
      <desc>Patient phone call at 24h</desc>
      <group_list>
        <group group_id="E1">
          <title>Oral Acetaminophen</title>
          <description>Oral Acetaminophen 1-hour before surgery
Oral Acetaminophen: 1000mg oral acetaminophen + 400mg oral celecoxib given within one hour of incision</description>
        </group>
        <group group_id="E2">
          <title>Intravenous Acetaminophen</title>
          <description>Intravenous Acetaminophen within 1-hour prior to anesthetic emergence
Intravenous acetaminophen: 400mg oral celecoxib given within one hour of incision + 1000mg IV acetaminophen within one hour prior to anesthetic emergence.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <description>Nausea following PACU discharge (assessed at 24h post-operatively)</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="51"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Single center Sinus surgery population only</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>David McDonagh, MD</name_or_title>
      <organization>UT Southwestern Medical Center</organization>
      <phone>214-648-8083</phone>
      <email>david.mcdonagh@utsouthwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

